Novartis Investigative Site

Heilbronn 74078

0 studies enrolling now · 6 studies all time

What they study most

Acute Heart Failure, Advanced Gastric Cancer, Atherosclerosis, Cardiovascular Disease, Chronic Heart Failure, Chronic Myeloid Leukemia, Type 2 Diabetes Mellitus

Studies at this site

• Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) — Completed
• Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients — Stopped early
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early